igella Sativa cardioprotective effect in Type 1 diabetes
Not Applicable
Recruiting
- Conditions
- Nutritional, Metabolic, EndocrinePaediatrics
- Registration Number
- PACTR202302478939306
- Lead Sponsor
- Faculty of Mediine Tanta Unversity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Type 1 diabetes children and adolescents with age 6-18 years
Exclusion Criteria
Clinical evidence of heart failure
coronary artery disease
systemic hypertension
rheumatic fever
cardiomyopathy,
The use of any medication other than insulin known to affect cardiac function (such as digitalis, angiotensin converting enzyme inhibitor, or ß-blocker)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method